Grayson Jordan
Family Medicine · Honea Path, SCNPI 1578913976
Payments from drug & device makers
Across 521 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$793
- AstraZeneca$792
- Novo Nordisk$632
- Lilly USA, LLC$624
- Pfizer$602
- plus $3K from 38 others
What the payments were for
- Food & beverage$8,063100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,063 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 112 | $124,601 |
| JardianceEmpagliflozin | 111 | $101,005 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 110 | $70,971 |
| OzempicSemaglutide | 50 | $69,730 |
| EliquisApixaban | 91 | $62,911 |
| JanuviaSitagliptin Phosphate | 52 | $43,298 |
| LinzessLinaclotide | 53 | $32,107 |
| TrulicityDulaglutide | 18 | $31,210 |
| EntrestoSacubitril/Valsartan | 23 | $25,952 |
| Bydureon BciseExenatide Microspheres | 20 | $22,381 |
| Repatha SureclickEvolocumab | 21 | $20,358 |
| VraylarCariprazine Hcl | 13 | $18,344 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $18,068 |
| XareltoRivaroxaban | 16 | $17,682 |
| MyrbetriqMirabegron | 25 | $14,878 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $624 | $155,811130 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat | $266 | $121,520150 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $161 | $82,057134 claims |
| Novo NordiskOzempic | $632 | $69,73050 claims |
| PfizerEliquis | $602 | $62,91191 claims |
| AbbVieLinzess, Vraylar, Qulipta | $1,503 | $62,77978 claims |
| MerckJanuvia | $81 | $43,29852 claims |
| NovartisEntresto | $339 | $25,95223 claims |
| Johnson & JohnsonXarelto | $36 | $17,68216 claims |
| Astellas Pharma US IncMyrbetriq | $15 | $14,87825 claims |
| AstraZenecaFarxiga | $792 | $10,70818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Honea Path
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.